Form 4: Sight Sciences Executive Sells Shares for Tax Cover
Statement of Changes in Beneficial Ownership
Sight Sciences' Chief Legal Officer, Jeremy B. Hayden, sold 12,733 shares of common stock to cover tax liabilities related to vested restricted stock units.
Summary
- Jeremy B. Hayden, Chief Legal Officer of Sight Sciences, Inc., reported a transaction on July 6, 2026.
- Hayden sold 12,733 shares of common stock.
- The sale was conducted to cover the Reporting Person's tax liability associated with the vesting of restricted stock units (RSUs).
- The shares were sold at a weighted average price of $5.508, with individual sales ranging from $5.37 to $5.62.
- Following this transaction, Hayden beneficially owns 357,037 shares of common stock, which includes 100,015 directly owned shares and 257,022 shares to be acquired upon the vesting and settlement of unvested RSUs.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as the transaction is a standard "sell to cover" for tax purposes and does not indicate a change in the executive's overall stake or sentiment towards the company.
Positives
- The transaction was a "sell to cover" to satisfy tax obligations, which is a common and expected event for executives receiving equity compensation.
- The executive retains a significant number of shares (357,037) and unvested RSUs, indicating continued commitment to the company.
Negatives
- A portion of the executive's equity compensation was converted to cash, reducing direct ownership of vested shares.
Future Outlook
No specific future outlook or guidance is provided in this filing, as it solely reports a past transaction.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into executive stock dealings. This specific filing details a common practice of executives selling shares to cover tax obligations arising from equity awards.
Stakeholder Impact
- Shareholders: The sale is a routine tax-related transaction by an executive and is not expected to have a significant impact on the share price or overall company performance.
Key Dates
| Date | Description |
|---|---|
| 07/06/2026 | Date of transaction and earliest transaction date reported. |
Keywords
Form 4, SEC Filing, Insider Transaction, Stock Sale, Restricted Stock Units, Tax Liability, Sight Sciences, SGHT, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.